TY - JOUR
T1 - Transient false-positive hepatobiliary scan associated with ceftriaxone therapy
AU - Lorberboym, Mordechai
AU - Machado, Maria
AU - Glajchen, Neville
AU - Pertsemlidis, Demetrius
PY - 1996/1
Y1 - 1996/1
N2 - Drug related false-positive hepatobiliary imaging is uncommon. The authors present a case of a 54-year-old woman who was treated with intravenous ceftriaxone for bacterial meningitis. Symptoms of acute cholecystitis subsequently developed and a sonogram revealed a gallstone. A Tc-99m DISIDA hepatobiliary study was positive for cystic duct obstruction. After discontinuation of ceftriaxone, the patient's clinical condition improved and, 2 weeks later, a repeat hepatobiliary scan was normal. High doses of ceftriaxone and prolonged administration may lead to formation of pseudocholelithiasis and signs of acute cholecystitis. Although this condition is usually benign and reversible, discontinuation of the drug is warranted when symptoms of acute cholecystitis are accompanied by a positive hepatobiliary scan.
AB - Drug related false-positive hepatobiliary imaging is uncommon. The authors present a case of a 54-year-old woman who was treated with intravenous ceftriaxone for bacterial meningitis. Symptoms of acute cholecystitis subsequently developed and a sonogram revealed a gallstone. A Tc-99m DISIDA hepatobiliary study was positive for cystic duct obstruction. After discontinuation of ceftriaxone, the patient's clinical condition improved and, 2 weeks later, a repeat hepatobiliary scan was normal. High doses of ceftriaxone and prolonged administration may lead to formation of pseudocholelithiasis and signs of acute cholecystitis. Although this condition is usually benign and reversible, discontinuation of the drug is warranted when symptoms of acute cholecystitis are accompanied by a positive hepatobiliary scan.
UR - https://www.scopus.com/pages/publications/0030028720
U2 - 10.1097/00003072-199601000-00002
DO - 10.1097/00003072-199601000-00002
M3 - Article
C2 - 8741880
AN - SCOPUS:0030028720
SN - 0363-9762
VL - 21
SP - 4
EP - 7
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 1
ER -